SOPHiA GENETICS SA (SOPH) - Multiplikator Forward P/S
SOPHiA GENETICS SA (SOPH) utilizes an elastic SaaS infrastructure to support the expansion of computing power for its multimodal AI cancer-fighting platform. The company's forward P/S ratio clearly demonstrates the market value's reaction to liquidity, with 7.40 representing the latest level. The development of the cloud ecosystem is driven by a staff of leading bioinformaticians attracted by flexible scheduling and an equity option system.
SOPH (sophiagenetics.com): rincian analitis lan laporan miturut indikator
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- statistik nilai buku emiten:
- rincian utang lan likuiditas:
Total Utang marang Modal SOPHiA GENETICS SA|SOPH - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas SOPHiA GENETICS|SOPH - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku SOPH|SOPH - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan SOPHiA GENETICS SA|Likuiditas cepet sophiagenetics.com
- rincian asil keuangan lan kelipatan valuasi:
SOPH - Asil keuangan resik|Bathi mangsa ngarep SOPHiA GENETICS SA|SOPH - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep SOPHiA GENETICS|SOPH - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA SOPH|SOPH - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan SOPHiA GENETICS SA|SOPH - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sophiagenetics.com|SOPH - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep SOPHiA GENETICS SA
- rincian pendapatan lan dodolan:
Analisis umum perusahaan:SOPHiA GENETICS S.A. SOPH
To objectively assess the operational success of SOPHiA GENETICS SA (SOPH), investors must understand the extent to which the market is willing to pay a premium for the scaling of a cloud-based genome analysis platform with a global subscription base. By analyzing the forward price-to-sales ratio, you can see the relationship between current market capitalization and projected sales, which allows for a determination of the level of optimism priced in and the risks of a correction should expansion slow.
Analisis perusahaan pesaing
Veeva - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DOCS|HealthEquity Corp - Multiplikator Forward P/S|Prakiraan rega marang pendapatan Waystar Corp (WAY)|CRVL: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep priviahealth.com (PRVA)|Rasio rega marang prakiraan pendapatan Huron|Kapitalisasi marang prakiraan pendapatan CERT (Certara Inc)|Multiplikator Forward P/S OMCL|GDRX - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Schrodinger, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake PHR (phreesia.com)|Omada Health - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Evolent Health Inc EVH|HSTM: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Definitive Corp|Rasio rega marang prakiraan pendapatan Consensus Cloud Solutions|agilonhealth.com (AGL) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ABSI (Absci Corporation)|SY (So-Young International Inc) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan National Research Corporation NRC|Rasio kapitalisasi marang dodolan sing dikarepake USA Mobility (SPOK)|OptimizeRx Corporation - Multiplikator Forward P/S|TBRG - Multiplikator Forward P/S|Simulations Plus (SLP) - Rasio rega marang prakiraan pendapatan|HCAT - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CareCloud Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Research Solutions Inc. RSSS|Rasio rega marang prakiraan pendapatan DLH Holdings Corp. (DLHC)|ONMD: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S SCNX (Scienture)|Rega forward marang dodolan HCTI|iSpecimen Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Bullfrog AI Holdings BFRG|WORX (SCWorx Corp.) - Multiplikator forward rega marang pendapatan|MSPR: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan ICCT|MEDS: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Orgenesis Corp (ORGS)|Multiplikator forward rega marang pendapatan r1rcm.com RCM|Multiplikator Forward P/S SHCR (Sharecare, Inc.)|streamlinehealth.net (STRM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Syra Health - Multiplikator Forward P/S|AMEH (Apollo Medical Holdings) - Kapitalisasi marang prakiraan pendapatan|Model N Corp (MODN) - Rasio rega marang prakiraan pendapatan|NXGN - Rasio kapitalisasi marang dodolan sing dikarepake
